arrow
J

Jonathan L. Koff

Wake Forest University
H指数:29
被引数:5,611

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Effects of Cyproheptadine on Severe COVID-19 From the I-SPY COVID Adaptive Platform Trial

Cyproheptadine对重症COVID-19的影响:来自I-SPY COVID适应性平台试验

2025-10-010
OAAI
Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis

个性化吸入用细菌噬菌体疗法治疗囊性纤维化患者中的多重耐药铜绿假单胞菌

2025-04-291
OA
A ventilated perfused lung model platform to dissect the response of the lungs to viral infection

一种通气血流灌注的肺模型平台,用于解析肺部对病毒感染的应答

2025-04-240
PRE
Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis

囊性纤维化患儿肺病恶化的流行病学变化

2025-02-280
OA
Clinical trial design during and beyond the pandemic: the I-SPY COVID trial
2022-01-2013
OA
A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the Future

冠状病毒后疾病2019康复的诊所蓝图从过去学习,展望未来

CHEST
IF8.6
2021-03-0147
OAAI
A neutrophil activation signature predicts critical illness and mortality in COVID-19

中性粒细胞激活特征预测新型冠状病毒肺炎的危重病和死亡率

2021-02-26208
OAAI
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
2020-08-01566
OAAI